Effectiveness of Haemophilus influenzae type b vaccination against bacterial pneumonia in Colombia

Vaccine

Volumn 23, Issue 1, 2004, Pages 36-42

  De La Hoz, Fernando ^a   Higuera, Ana Betty ^a   Fabio, Jose Luis Di ^b   Luna, Mauricio ^c   Naranjo, Alberto Gómez ^c   Valencia, María De La Luz ^d   Pastor, Desiree ^e   Hall, Andrew J ^f  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c Instituto de Los Seguros Sociales   (Colombia)

^d UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^e Edif Aurora 9 Piso Bogota C   (Guyana)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Colombia; Effectiveness; Hib; Pneumonia; Vaccine

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; POLYSACCHARIDE ANTIGEN PRF; POLYSACCHARIDE VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL PNEUMONIA; CHILD HEALTH CARE; COLOMBIA; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; SOCIAL CLASS; STREPTOCOCCUS PNEUMONIAE; X RAY;

CASE-CONTROL STUDIES; COLOMBIA; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; INFANT, NEWBORN; PNEUMONIA, BACTERIAL;

EID: 7444260307     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.05.017     Document Type: Article

References (17)

1. OPS. Enfermedades Transmisibles. Control de las infecciones respiratorias agudas, Washington; 1997. p. 1-7.
2. OMS, Unicef(f), UNDP. Reunión consultiva internacional sobre el control de las infecciones respiratorias agudas (RCICIRA). Neumonía en los nios: Estrategias para hacer frente al desafío. Washington, DC; 1991. p. 1-13.
3. OPS/OMS. Situación de Salud en las Américas. Indicadores Básicos. Programa Especial de Análisis en Salud (SHA). Washington; 2000 (Accessed October 10, 2002. at http://www.ops.org).
4. OPS/OMS. Situación de Salud en las Américas. Volúmen I-II. Washington; 1998.
5. Benguigui Y, López F, Schmunis G, Yunes J. Infecciones Respiratorias en Nios. Organización Panamericana de la Salud/Organización Mundial de la Salud. HCT/AIEPI-1.E. Washington, DC, 1997.
6. OPS. Programa especial para Vacunas e Inmunizaciones (SVI). Reunión para el establecimiento de un sistema de vigilancia epidemiológica en Centro América para Hib y S. pneumoniae. Managua, Nicaragua; 1998.
7. H. Schneerson, O. Barrera, A. Sutton, and J.B. Robbins Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide proteín conjugates J Exp Med. 152 1980 361 376
8. B. Claesson, B. Trollfors, and T. Lagergard Clinical and immunological responses to capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18 to 23 months old boys J Pediatr. 112 1988 695 702
9. B.A. Claesson, R. Schneerson, and J.B. Robbins Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae capsular polysaccharide tetanus toxoid conjugate J Pediatr. 114 1989 97 100
10. M.D. Decker, K.M. Edwards, R. Bradley, and P. Palmer Four conjugate Haemophilus influenzae b vaccine infants: a comparative trial. Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy Atlanta, Georgia 1990 21 24
11. Roa JA, Echandía CA. Emergencias y Urgencias en Pediatría. Neumonías 102-110. Guías anticipatorias. Segunda edición. Cali; 2001
12. K. Mullholland, S. Hilton, and R. Adegbola Randomised trial of Haemophilus influenzae type b tetanus protein conjugated for prevention for pneumonia and meningitis in Gambian infants Lancet 349 1997 1191 1197
13. J. Schlesseman Case control studies Design, conduct analysis 1982 Oxford University Press
14. O.S. Levine, R. Lagos, A. Muoz, J. Villaroel, A. Alvarez, and P. Abrego Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b Pediatric Infect Dis J 18 12 1999 1060 1064
15. L. Moulton, S. Chung, J. Croll, R. Reid, R. Weatherholtz, and M. Santosham Estimation of the indirect effect of Haemophilus influenzae type b vaccine in an American Indian population Int. J. Epidemiol. 29 2000 753 756
16. N. Wilson, J. Wenger, O. Mansoor, M. Baker, and D. Martin The beneficial impact of Hib vaccine on disease rates in New Zealand children NZ Med J 115 2002 122 127
17. H. Jafari, W. Adams, and K. Robinson Efficacy of Hib conjugate vaccine and persistence of disease in disadvantaged populations Am J Pub Health 89 3 1999 364 368